US Broker Ratings

Precigen, Inc. (PGEN) Stock Analysis: A Biotech Player with Over 100% Upside Potential

Precigen, Inc. (NASDAQ: PGEN) is garnering attention in the biotechnology sector with a striking potential upside of over 100%. As a discovery and clinical-stage biopharmaceutical company, Precigen is making waves..

Prothena Corporation plc (PRTA) Stock Analysis: Exploring a Promising 119% Potential Upside in the Biotech Sector

Prothena Corporation plc (NASDAQ: PRTA), an Irish biotechnology firm, has captured the attention of investors with its robust product pipeline targeting diseases caused by protein dysregulation. With a current market..

Iovance Biotherapeutics, Inc. (IOVA) Stock Analysis: Unveiling a 276% Potential Upside in the Biotech Arena

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a prominent player in the biotechnology sector, is drawing significant attention from investors due to its potential upside of 276.13%. This San Carlos, California-based company..

Auna SA (AUNA) Stock Analysis: Exploring a 90.63% Potential Upside in Healthcare

Investors seeking opportunities in the healthcare sector might find Auna SA (AUNA) an intriguing prospect, as its current market dynamics present a significant potential upside. Operating within the medical care..

OrthoPediatrics Corp. (KIDS) Stock Analysis: A Promising Growth in Pediatric Orthopedics with 28.94% Potential Upside

OrthoPediatrics Corp. (NASDAQ: KIDS), a prominent player in the healthcare sector, is carving a niche in the medical devices industry by focusing on pediatric orthopedics. Headquartered in Warsaw, Indiana, this..

Semler Scientific, Inc. (SMLR) Stock Analysis: A Medical Device Innovator with 223% Potential Upside

Semler Scientific, Inc. (NASDAQ: SMLR), a player in the healthcare sector specializing in medical devices, presents an intriguing opportunity for investors with its remarkable potential upside of 223%. This California-based..

Castle Biosciences, Inc. (CSTL) Stock Analysis: Navigating the Diagnostics Frontier with a Promising 12.88% Upside

Castle Biosciences, Inc. (NASDAQ: CSTL) is making waves in the healthcare sector, particularly in the diagnostics and research industry. With a market capitalization of $1.19 billion, this molecular diagnostics company..

Organogenesis Holdings Inc. (ORGO) Stock Report: Analyzing a 114% Potential Upside in Regenerative Medicine

Organogenesis Holdings Inc. (NASDAQ: ORGO), a key player in the regenerative medicine sector, is drawing attention from investors with its significant potential upside of 114.11%. Specializing in advanced wound care..

Septerna, Inc. (SEPN) Stock Report: Exploring a 21% Potential Upside Amidst Robust Growth Prospects

Septerna, Inc. (SEPN), a dynamic player in the biotechnology sector, is gaining attention from investors seeking high-growth opportunities in the healthcare industry. Founded in 2019 and headquartered in South San..

Celcuity Inc. (CELC): Investment Insights on a Biotech Trailblazer with Strong Buy Ratings

For investors with a keen eye on the biotechnology sector, Celcuity Inc. (NASDAQ: CELC) presents an intriguing opportunity. With a market capitalization of $4.87 billion, this clinical-stage biotech firm is..

Oric Pharmaceuticals, Inc. (ORIC) Stock Analysis: Exploring an 82% Potential Upside in the Biotech Sector

Oric Pharmaceuticals, Inc. (NASDAQ: ORIC) is gaining attention in the biotech sector, not only because of its innovative approach to tackling cancer resistance mechanisms but also due to its significant..

Verastem, Inc. (VSTM): Investor Outlook on Biotech’s 144% Potential Upside

Verastem, Inc. (NASDAQ: VSTM) has emerged as a biotech company capturing attention with its promising pipeline and significant upside potential. With its current market capitalization of $497.11 million, Verastem focuses..

Enhabit, Inc. (EHAB) Stock Analysis: Navigating Potential Upside with a Focused Healthcare Strategy

Enhabit, Inc. (NASDAQ: EHAB), a significant player in the U.S. healthcare sector, offers a compelling investment opportunity for those looking to enter the medical care facilities industry. With a market..

AtaiBeckley Inc. (ATAI): Biotechnology Innovator with a 234% Potential Upside

AtaiBeckley Inc. (NASDAQ: ATAI), a prominent player in the biotechnology sector, is making significant strides in developing innovative mental health treatments. With a market capitalization of $1.35 billion, AtaiBeckley is..

Amylyx Pharmaceuticals, Inc. (AMLX) Stock Analysis: Exploring 49.57% Potential Upside

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) stands out in the healthcare sector as a dynamic player within the specialty and generic drug manufacturing industry. With a market capitalization of $1.48 billion,..

MBX Biosciences, Inc. (MBX) Stock Analysis: Exploring a 45% Potential Upside in the Biotech Sector

MBX Biosciences, Inc. (MBX), a clinical-stage biopharmaceutical company, is gaining attention in the biotechnology sector with its focused approach on precision peptide therapies designed to address endocrine and metabolic disorders...

COMPASS Pathways Plc (CMPS) Stock Analysis: A Look at a Promising 130% Upside in Mental Health Innovation

COMPASS Pathways Plc (NASDAQ: CMPS) is gaining attention in the healthcare sector, particularly among investors intrigued by its role in revolutionizing mental health treatment. With a market cap of $701.88..

Tyra Biosciences, Inc. (TYRA): Investor Outlook on a Promising Biotech with 15.68% Upside Potential

Tyra Biosciences, Inc. (NASDAQ: TYRA), a clinical-stage biotechnology company headquartered in Carlsbad, California, is garnering significant attention in the healthcare sector. With a market capitalization of $1.55 billion, Tyra is..

PureTech Health (PRTC) Stock Analysis: Unveiling the 542.7% Revenue Growth in Biotech Innovation

In the fast-paced world of biotechnology, PureTech Health plc (NASDAQ: PRTC) is emerging as a compelling player, sparking interest with its remarkable 542.7% revenue growth. As a leader in developing..

InnovAge Holding Corp. (INNV) Stock Analysis: Navigating Through Healthcare Challenges with a 15.10% Revenue Growth

InnovAge Holding Corp. (INNV) has carved a niche within the healthcare sector, specializing in medical care facilities tailored for seniors. The company, with a market capitalization of $793.74 million, plays..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds